Angela M. Feraco

Also affiliated with Dana-Farber Cancer Institute, Dana-Farber/Boston Children's Cancer and Blood Disorders Center

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Disease site number was not prognostic in a low-risk Hodgkin lymphoma combined modality trial: revisiting PHC HOD90”.

Disease site number was not prognostic in a low-risk Hodgkin lymphoma combined modality trial: revisiting PHC HOD90

Blood Advances(2023)10.1182/bloodadvances.2023010944

N/A

0DataRank · unranked

0 citations

Yiwang Zhou, Ying Zheng, Lianna J. Marks, Alison M. Friedmann, Howard J. Weinstein +3 more